Different inhibitor incidence for individual factor VIII concentrates in 1076 previously untreated patients with severe hemophilia A: data from the PedNet cohort

被引：2

作者：

Fischer, Kathelijn ^{[1
,14
]}

Carcao, Manuel ^{[2
]}

Male, Christoph ^{[3
]}

Ranta, Susanna ^{[4
]}

Pergantou, Helen ^{[5
]}

Kenet, Gili ^{[6
]}

Kartal-Kaess, Mutlu ^{[7
]}

Koenigs, Christoph ^{[8
]}

Carvalho, Manuela ^{[9
]}

Alvarez, Maria Teresa ^{[10
]}

Brakenhoff, Timo ^{[11
]}

Chambost, Herve ^{[12
]}

van den Berg, H. Marijke ^{[13
]}

机构：

[1] Univ Utrecht, Univ Med Ctr, Ctr Benign Hematol Thrombosis & Hemostasis, Creveldklin, Utrecht, Netherlands

[2] Hosp Sick Children, Div Haematol Oncol, Toronto, ON, Canada

[3] Med Univ Hosp Vienna, Dept Paediat, Vienna, Austria

[4] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Pediat Coagulat Unit, Stockholm, Sweden

[5] St Sophia Childrens Hosp, Haemophilia Haemostasis Unit, Athens, Greece

[6] Tel Aviv Univ, Tel Hashomer & Amalia Biron Res Inst Thrombosis &, Natl Hemophilia Ctr, Sheba Med Ctr, Tel Aviv, Israel

[7] Univ Bern, Univ Hosp, Inselspital, Dept Pediat,Div Pediat Hematol & Oncol, Bern, Switzerland

[8] Univ Hosp Frankfurt, Dept Paediat & Adolescent Med, Frankfurt, Germany

[9] Ctr Referencia Coagulopatias Congenitas Ctr Hospit, EPE, Porto, Portugal

[10] Hop Univ La Paz, Unidad Coagulopatias, Madrid, Spain

[11] Julius Clin, Zeist, Netherlands

[12] Aix Marseille Univ, AP HM, Ctr Traitement lHemophilie, Marseille, France

[13] PedNet Haemophilia Res Fdn, Baarn, Netherlands

[14] Univ Med Ctr Utrecht, Creveldklin, Room C02 048,POB 85500, NL-3508 GA Utrecht, Netherlands

来源：

JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2023年 / 21卷 / 03期

关键词：

PRODUCTS; BOYS;

D O I：

10.1016/j.jtha.2022.11.020

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：700 / 703

页数：4

共 10 条

[1] Analyses of the FranceCoag cohort support differences in immunogenicity among one plasma-derived and two recombinant factor VIII brands in boys with severe hemophilia A [J].

Calvez, Thierry ;

Chambost, Herve ;

d'Oiron, Roseline ;

Dalibard, Vincent ;

Demiguel, Virginie ;

Doncarli, Alexandra ;

Gruel, Yves ;

Huguenin, Yoann ;

Lutz, Patrice ;

Rothschild, Chantal ;

Vinciguerra, Christine ;

Goudemand, Jenny .

HAEMATOLOGICA, 2018, 103 (01) :179-189

[2] Recombinant factor VIII products and inhibitor development in previously untreated boys with severe hemophilia A [J].

Calvez, Thierry ;

Chambost, Herve ;

Claeyssens-Donadel, Segolene ;

d'Oiron, Roseline ;

Goulet, Veronique ;

Guillet, Benoit ;

Heritier, Virginie ;

Milien, Vanessa ;

Rothschild, Chantal ;

Roussel-Robert, Valerie ;

Vinciguerra, Christine ;

Goudemand, Jenny .

BLOOD, 2014, 124 (23) :3398-3408

[3]

Committee for Medicinal Products for Human Use (CHMP), 2011, EMACHMPBPWP144533200

[4] Prospective observational cohort studies for studying rare diseases: the European PedNet Haemophilia Registry [J].

Fischer, K. ;

Ljung, R. ;

Platokouki, H. ;

Liesner, R. ;

Claeyssens, S. ;

Smink, E. ;

Van den Berg, H. M. .

HAEMOPHILIA, 2014, 20 (04) :e280-e286

[5] Factor VIII Products and Inhibitor Development in Severe Hemophilia A [J].

Gouw, Samantha C. ;

van der Bom, Johanna G. ;

Ljung, Rolf ;

Escuriola, Carmen ;

Cid, Ana R. ;

Claeyssens-Donadel, Segolene ;

van Geet, Christel ;

Kenet, Gili ;

Makipernaa, Anne ;

Molinari, Angelo Claudio ;

Muntean, Wolfgang ;

Kobelt, Rainer ;

Rivard, George ;

Santagostino, Elena ;

Thomas, Angela ;

van den Berg, H. Marijke .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (03) :231-239

[6] Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma-derived or recombinant factor VIII concentrates: a systematic review [J].

Iorio, A. ;

Halimeh, S. ;

Holzhauer, S. ;

Goldenberg, N. ;

Marchesini, E. ;

Marcucci, M. ;

Young, G. ;

Bidlingmaier, C. ;

Brandao, L. R. ;

Ettingshausen, C. E. ;

Gringeri, A. ;

Kenet, G. ;

Knoefler, R. ;

Kreuz, W. ;

Kurnik, K. ;

Manner, D. ;

Santagostino, E. ;

Mannucci, P. M. ;

Nowak-Goettl, U. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (06) :1256-1265

[7]

pednet eu, US

[8] A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A [J].

Peyvandi, F. ;

Mannucci, P. M. ;

Garagiola, I. ;

El-Beshlawy, A. ;

Elalfy, M. ;

Ramanan, V. ;

Eshghi, P. ;

Hanagavadi, S. ;

Varadarajan, R. ;

Karimi, M. ;

Manglani, M. V. ;

Ross, C. ;

Young, G. ;

Seth, T. ;

Apte, S. ;

Nayak, D. M. ;

Santagostino, E. ;

Mancuso, M. E. ;

Sandoval Gonzalez, A. C. ;

Mahlangu, J. N. ;

Bonanad Boix, S. ;

Cerqueira, M. ;

Ewing, N. P. ;

Male, C. ;

Owaidah, T. ;

Soto Arellano, V. ;

Kobrinsky, N. L. ;

Majumdar, S. ;

Perez Garrido, R. ;

Sachdeva, A. ;

Simpson, M. ;

Thomas, M. ;

Zanon, E. ;

Antmen, B. ;

Kavakli, K. ;

Manco-Johnson, M. J. ;

Martinez, M. ;

Marzouka, E. ;

Mazzucconi, M. G. ;

Neme, D. ;

Palomo Bravo, A. ;

Paredes Aguilera, R. ;

Prezotti, A. ;

Schmitt, K. ;

Wicklund, B. M. ;

Zulfikar, B. ;

Rosendaal, F. R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (21) :2054-2064

[9] Meta-analysis on incidence of inhibitors in patients with haemophilia A treated with recombinant factor VIII products [J].

Rota, Matteo ;

Cortesi, Paolo A. ;

Steinitz-Trost, Katharina N. ;

Reininger, Armin J. ;

Gringeri, Alessandro ;

Mantovani, Lorenzo G. .

BLOOD COAGULATION & FIBRINOLYSIS, 2017, 28 (08) :627-637

[10] Recombinant factor VIII products and inhibitor development in previously untreated patients with severe haemophilia A: Combined analysis of three studies [J].

Volkers, Peter ;

Hanschmann, Kay-Martin ;

Calvez, Thierry ;

Chambost, Herve ;

Collins, Peter W. ;

Demiguel, Virginie ;

Hart, Daniel P. ;

Hay, Charles R. M. ;

Goudemand, Jenny ;

Ljung, Rolf ;

Palmer, Ben P. ;

Santagostino, Elena ;

van Hardeveld, Ella M. ;

van den Berg, Marijke ;

Keller-Stanislawski, Brigitte .

HAEMOPHILIA, 2019, 25 (03) :398-407

← 1 →